Work

The Phase 3 PREVAIL Study Assessing the Efficacy and Safety of Subcutaneous Gefurulimab in Adults with Generalized Myasthenia Gravis: Trial in Progress (P7-11.021)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000208763

Authors: James Howard, Kelly Gwathmey, Chongbo Zhao, Sanjay Rakhade, Joachim Scholz, Alexandra Peláez-Rivas, Annie Racine, Alanna McEneny, Shulian Shang, Tuan Vu

Institutions: University of North Carolina at Chapel Hill, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, Fudan University, Huashan Hospital, University of South Florida

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409222586

FWCI: 1.096

Cites:

Cited by: 2

Related to: 10